Product
hyoscine-n-butylbromide
1 clinical trial
2 indications
Indication
Endometrial CancerIndication
Ovarian CancerClinical trial
4FMFES Positron Emission Tomography (PET) for Detection of Newly-diagnosed ER+ Endometrial and Ovarian CancersStatus: Completed, Estimated PCD: 2023-08-31